Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV ΔNS2/Δ1313/I1314L Vaccine; Biological: RSV 6120/ΔNS2/1030s Vaccine; Biological: RSV 276 Vaccine; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Membranous Nephropathy; MN
Interventions: Drug: Belimumab; Drug: Placebo for Belimumab; Drug: Rituximab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN); GlaxoSmithKline
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: HIV/AIDS; Alcoholic Hepatitis
Interventions: Other: Alcoholic Hepatitis Group; Other: Heavy Drinking Controls without Hepatitis
Sponsor: Indiana University
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Opioid-Related Disorders
Intervention: Device: Deep Brain Simulator
Sponsors: West Virginia University; National Institute on Drug Abuse (NIDA); Medtronic
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Bacterial Vaginoses
Interventions: Drug: Metronidazole Oral; Drug: Placebo Oral Tablet
Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Hepatitis C; Opioid-Related Disorders; Injection Drug Use
Intervention: Drug: Sofosbuvir/velpatasvir (Epclusa®)
Sponsors: Jennifer Havens; National Institute on Drug Abuse (NIDA); National Cancer Institute (NCI); Gilead Sciences; University of Kentucky; Icahn School of Medicine at Mount Sinai; University of Bristol
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Cytomegalovirus Infections; Kidney Transplant Infection
Intervention: Biological: CMV specific T-cells
Sponsors: University of Wisconsin, Madison; University of Wisconsin Program for Advanced Cell Therapy (PACT); University of Wisconsin School of Medicine and Public Health (UWSMPH); UW Health
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Pilonidal Disease
Intervention: Procedure: Laser hair removal
Sponsor: University of Wisconsin, Madison
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Cytomegalovirus Infection
Interventions: Drug: Letermovir; Drug: Placebo
Sponsor: Merck Sharp & Dohme Corp.
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Septicemia
Intervention: Procedure: Biospecimen Collection
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI); National Institute of General Medical Sciences (NIGMS)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days




